Skip to menu Skip to content Skip to footer
Emeritus Professor Sue Tett
Emeritus Professor

Sue Tett

Email: 

Overview

Background

Professor Susan Tett is a registered pharmacist with research interests in Quality Use of Medicines (improving how medicines are used) and clinical pharmacokinetics (optimising medicine doses)

Sue completed her PhD in 1988. Since this time she has been in research positions and in academia at Sydney University, St Vincent’s Hospital, Sydney and at the University of Queensland. She has over 150 peer reviewed research publications and over 200 conference presentations and is on Editorial Board of Clinical Pharmacokinetics. Sue was Head of the School of Pharmacy, University of Queensland 1996-2004 and Deputy Executive Dean & Associate Dean Research for the Faculty of Health Sciences 2006-2010, including periods as Acting Executive Dean.

Susan Tett has been a member of many Australian national and State advisory committees, including Pharmaceutical Health and Rational use of Medicines Committee 1996-2004, Pharmaceutical Sub-Committee of the Australian Drug Evaluation Committee 1995-2004, Pharmaceutical Industry Working Group 2003-10 , Pharmaceutical Partnerships Program Committee of the Industry Research & Development Board 2003-09, and has participated in NHMRC Project Grant Review Panels and Fellowships Panels. She was also Councillor for the Pharmaceutical Society of Australia (Queensland Branch) and was the Australian Pharmacist of the Year in 1999, for her contributions to pharmacy education and research.

Sue’s research interests are directed towards optimising the clinical use of medications. General areas of research include quality use of medicines, clinical pharmacokinetics and pharmacodynamics. Sue supervises a number of postgraduate students and is actively involved in innovation in the pharmacy profession, pushing the professional boundaries. She is committed to enhancing the role of the health care team in optimising consumer health outcomes.

Availability

Emeritus Professor Sue Tett is:
Available for supervision
Media expert

Qualifications

  • Bachelor (Honours), University of Sydney
  • Doctor of Philosophy, University of Sydney

Research interests

  • Clinical pharmacokinetics and pharmacodynamics

    Many projects being undertaken to define better dosing options to give improved patient outcomes - eg. in people who have received organ transplants (tacrolimus, mycophenolate, sirolimus) or who need other immunosuppressants (eg. leflunomide in people with rheumatoid arthritis).

  • Quality use of Medicines

    Numerous projects designed to improve how medicines are used - particular interests in health care teams, including consumers; rural health; medication use and misuse and international comparisons of prescription medication use

Works

Search Professor Sue Tett’s works on UQ eSpace

309 works between 1985 and 2020

1 - 20 of 309 works

Featured

2013

Journal Article

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease

Abd Rahman, Azrin N., Tett, Susan E. and Staatz, Christine E. (2013). Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease. Clinical Pharmacokinetics, 52 (5), 303-331. doi: 10.1007/s40262-013-0039-8

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease

Featured

2013

Journal Article

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada

Tett, Susan E., Sketris, Ingrid, Cooke, Charmaine, Velhuyzen van Zanten, Sander and Barozzi, Nadia (2013). Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiology and Drug Safety, 22 (7), 735-743. doi: 10.1002/pds.3442

Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada

Featured

2011

Journal Article

Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?

Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000

Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?

Featured

2011

Journal Article

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

Tett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001

Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure

Featured

2011

Journal Article

How is medication prescribing ceased? A systematic review

Ostini, Remo, Jackson, Claire, Hegney, Desley and Tett, Susan E. (2011). How is medication prescribing ceased? A systematic review. Medical Care, 49 (1), 24-36. doi: 10.1097/MLR.0b013e3181ef9a7e

How is medication prescribing ceased? A systematic review

Featured

2009

Journal Article

The Australian rise of esomeprazole-was expenditure on samples a contributor?

Kyle, G. J., Nissen, L. M. and Tett, S. E. (2009). The Australian rise of esomeprazole-was expenditure on samples a contributor?. Pharmacoepidemiology and Drug Safety, 18 (1), 62-68. doi: 10.1002/pds.1685

The Australian rise of esomeprazole-was expenditure on samples a contributor?

Featured

2009

Journal Article

Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing

Barozzi, N. and Tett, S. E. (2009). Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing. Clinical Therapeutics, 31 (4), 849-861. doi: 10.1016/j.clinthera.2009.04.012

Gastroprotective drugs in Australia: Utilization patterns between 1997 and 2006 in relation to NSAID prescribing

Featured

2008

Journal Article

Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use

Ostini, R., Hegney, D., Mackson, J. M., Williamson, M and Tett, S.E. (2008). Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiology and Drug Safety, 17 (11), 1077-1090. doi: 10.1002/pds.1638

Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use

Featured

2008

Journal Article

A comparison of benzodiazepine and related drug use in Nova Scotia and Australia

Smith, Alesha J., Sketris, Ingrid, Cooke, Charmaine, Gardner, David, Kisely, Steve and Tett, Susan E. (2008). A comparison of benzodiazepine and related drug use in Nova Scotia and Australia. The Canadian Journal of Psychiatry, 53 (8), 545-552. doi: 10.1177/070674370805300809

A comparison of benzodiazepine and related drug use in Nova Scotia and Australia

2020

Journal Article

Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients

Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2020). Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients. Therapeutic Drug Monitoring, 43 (2), 238-246. doi: 10.1097/ftd.0000000000000814

Evaluation of Bayesian forecasting methods for prediction of tacrolimus exposure using samples taken on two occasions in adult kidney transplant recipients

2019

Journal Article

Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients

Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y

Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients

2019

Journal Article

Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients

Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687

Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients

2019

Conference Publication

Saliva prednisolone measurements in adult kidney transplant recipients

Staatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019.

Saliva prednisolone measurements in adult kidney transplant recipients

2018

Journal Article

Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?

Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8

Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?

2018

Journal Article

Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports

Jones, Mark, Tett, Susan E. and Del Mar, Chris (2018). Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports. Pharmacoepidemiology and Drug Safety, 27 (11), 1217-1222. doi: 10.1002/pds.4651

Psychiatric adverse events in oseltamivir prophylaxis trials: novel comparative analysis using data obtained from clinical study reports

2018

Journal Article

Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

Brooks, Emily K, Staatz, Christine E, Tett, Susan E, Isbel, Nicole M and McWhinney, Brett (2018). Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients. Therapeutic Drug Monitoring, 40 (2), 195-201. doi: 10.1097/FTD.0000000000000486

Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

2018

Conference Publication

Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.

Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.. American Transplant Congress, Seattle, WA United States, 2-6 June 2018. Hoboken, NJ United States: Wiley.

Evaluation of multiple linear regression limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients.

2018

Conference Publication

Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone

Brooks, E., Tett, S. E., Isbel, N. and Staatz, C. E. (2018). Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone. RACP Trainee Research Awards, Brisbane, QLD Australia, 7 November 2018.

Saliva prednisolone in adult kidney transplant recipients receiving triple therapy with tacrolimus, mycophenolate sodium and prednisolone

2018

Conference Publication

Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.

Brooks, E., Tett, S. E., Isbel, N. M., McWhinney, B. and Staatz, C. E. (2018). Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology Brisbane, Brisbane, QLD Australia, 16-19 September 2018.

Saliva mycophenolic acid monitoring following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients.

2017

Journal Article

Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis

Abd Rahman, Azrin N, Tett, Susan E, Abdul Gafor, Halim A, McWhinney, Brett C and Staatz, Christine E (2017). Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis. European journal of drug metabolism and pharmacokinetics, 42 (6), 993-1004. doi: 10.1007/s13318-017-0420-3

Development of Improved Dosing Regimens for Mycophenolate Mofetil Based on Population Pharmacokinetic Analyses in Adults with Lupus Nephritis

Funding

Past funding

  • 2014 - 2015
    Fun 'n fitness: Evaluation of the Churches of Christ in Queensland Falls Prevention Exercise Program for its Aged Care Residents
    Churches of Christ in Queensland
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2013 - 2014
    Utilisation review of Ezetimibe
    Department of Health and Ageing
    Open grant
  • 2009 - 2010
    Safety and quality of medication use - can this be improved through understanding/building on health professional networks
    The JO and JR Wicking Trust
    Open grant
  • 2009 - 2011
    QUMmap and website
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2009 - 2010
    Uni of Southampton Evaluation of Nurse & Pharmacist Prescribing
    University of Southampton
    Open grant
  • 2009 - 2013
    Commercial influences on community pharmacist recommendations and their impact on patient's quality use of medicines
    Pharmacists Board of Queensland
    Open grant
  • 2008 - 2009
    QUMmap and Website June 2008
    Department of Health and Ageing (Commonwealth of Australia)
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    Pilot study to include community pharmacies in distribution of prescription medicine starter packs
    Pharmaceutical Society of Australia
    Open grant
  • 2007
    Prescription medicine samples and therapy initiation: developing a best practice system with community pharmacists in Australia
    Pharmaceutical Society of Australia
    Open grant
  • 2006 - 2008
    Understanding and Improving Prescribing Practice
    National Prescribing Service Limited
    Open grant
  • 2006 - 2008
    Maintenance and Promotion of the QUMMAP
    Department of Health and Ageing
    Open grant
  • 2005 - 2011
    Multicentre Drug Use Evaluation and other quality use of medicines activities in hospitals
    National Prescribing Service Limited
    Open grant
  • 2004 - 2006
    National Strategy for Quality Use of Medicines
    Department of Health and Ageing
    Open grant
  • 2004 - 2005
    NHMRC_Equipment Grant_HLTH_Pharmacy
    NHMRC Equipment Grant
    Open grant
  • 2003 - 2005
    Multi-centre drug use evaluation in hospitals
    National Prescribing Service Limited
    Open grant
  • 2003 - 2005
    Rural Community Pharmacists Integrating Care for People With Complex Health Needs
    Pharmacy Guild of Australia
    Open grant
  • 2003 - 2005
    Rural community pharmacists integrating care for people with complex health needs.
    Department of Health and Ageing
    Open grant
  • 2002 - 2003
    The Maintenance and promotion of the quality use of medicines mapping project website.
    Department of Health and Ageing
    Open grant
  • 2002
    Community pharmacists providing clinical services for dispensing doctors and depot pharmacies in rural Queensland - telepharmacy
    Pharmacy Guild of Australia
    Open grant
  • 2002 - 2005
    Pharmacokinetic and pharmacodynamic studies of the newer immunosuppressants
    NHMRC Project Grant
    Open grant
  • 2000 - 2001
    Appropriate prescriptyion of ipratropium bromide, including route of administration, both in hospital and on discharge
    National Prescribing Service Limited
    Open grant
  • 2000 - 2001
    Quality Use of Medicines Research
    Queensland Health
    Open grant
  • 1999 - 2001
    Pharmacists assisting GP's in the co-ordination of care for complex needs patients in rural and remote areas
    Pharmacy Guild of Australia
    Open grant
  • 1999 - 2001
    Population pharmacokinetics, pharmacodynamics and dosage prediction for tacrolimus
    NHMRC Project Grant
    Open grant
  • 1999
    The use of therapeutic flags to highlight potentially inappropriate prescribing in the elderley
    National Prescribing Service Limited
    Open grant
  • 1997 - 2000
    Quality use of medication, pharmacokinetics, pharmacodynamics and optimal dose prediction
    NHMRC Project Grant
    Open grant
  • 1996 - 1998
    Fluconazole renal elimination processes in HIV infection and iatrogenic immunosuppression
    NHMRC Project Grant - HIV/AIDS (CARG)
    Open grant
  • 1995 - 1996
    Rational therapy of rheumatic disease with hydroxychloroquine
    Sterling Pharmaceuticals Pty Limited
    Open grant

Supervision

Availability

Emeritus Professor Sue Tett is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Towards optimal dosing of new immunosuppressant drugs in solid organ transplants

    Improving dosing of immunosuppressant medications in people who have received solid organ transplants. Studies with tacrolimus, mycophenolate or sirolimus can be offered

  • International comparisons of medicines use, investigating pharmaceutical policy and other influences on usage

    International comparisons of the use of prescription medicines are important to improve the quality use of medicines across different jurisdictions. Lessons learned from one area can be translated into interventions to be applied to improve medicine use across a number of different health care systems

  • Factors affecting prescribing and use of medicines, including the influence of various marketing strategies (eg. free prescription medicine samples), the influence of location (eg. rural, remote) and

    Many factors are know to affect prescribing and use of medicines. Projects in this area will be designed to investigate specific aspects of these factors eg. effects of remote location, influence of free sample medications etc etc

  • Drug usage evaluation across different jurisdictions

    Drug usage evaluation, including the feedback, intervention and re-evaluation stages can influence how medicines are prescribed and used. Multicentre studies can have wide ranging influence, and studies across several jurisdictions (eg. hospital/community; public/private) can influence quality use of medicines in sustainable ways across large geographical areas. Projects are offered in the areas, particularly focussing on multi-disciplinary teams and multi-jurisdictional influences

  • Population Pharmacokinetics and Pharmacodynamics of the Newer Immunosuppressant Drug

Supervision history

Completed supervision

Media

Enquiries

Contact Emeritus Professor Sue Tett directly for media enquiries about:

  • Clinical pharmacokinetics
  • Clinical pharmacy
  • Medicine - quality use of
  • Pharmacokinetics
  • Pharmacy - clinical

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au